As evidenced by the improvement in RPE cell metabolism resulting from HIF-1α silencing, this approach may serve as a viable strategy for early intervention in age-related visual disorders, such as AMD, preceding the irreversible damage that can be caused to RPE cells and photoreceptors. The gene discussed is HIF1A; the disease is age-related macular degeneration.